Anti-SARS-CoV-2 Antibody (Bebtelovimab)
Catalog No.
F1023
Anti-SARS-CoV-2 Antibody (Bebtelovimab)
Featured Products
Bebtelovimab is targetedSARS-CoV-2, especially human IgG1-λ2 antibodies for COVID-19. Bebtelovimab can effectively neutralize SARS-CoV-2 variants and inhibit COVID-19 with mild to moderate efficacy.
143.82 kDa
Dry ice
2578319-11-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
LY-COV 1404, LY-3853113
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
SARS-CoV-2
Please avoid freeze-thaw cycles.